|
|
Article: Yale BioHaven Entrepreneurship Seminars Begin with BioRelix: "Switching to New Forms of Antibiotics".
- Article from:
- M2 Presswire
- Article date:
- October 23, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-23 October 2007-Yale University: Yale BioHaven Entrepreneurship Seminars Begin with BioRelix: "Switching to New Forms of Antibiotics"(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:22102007
New Haven, Conn. -- The Yale BioHaven Entrepreneurship Seminars series will begin its fall schedule with a program on the New Haven start-up company BioRelix Inc. on Wednesday, October 24 from 4 to 5 p.m. in the Anlyan Center Auditorium, Yale School of Medicine, 300 Cedar Street.
BioRelix, Inc. is working to identify antibiotics that target pathogens resistant to currently available drugs using novel patented bacterial RNA targets called ...